Stockholm - Delayed Quote SEK
Enorama Pharma AB (publ) (ERMA.ST)
3.0900
0.0000
(0.00%)
At close: April 24 at 3:56:14 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-46,556
-35,702
-41,349
-32,958
-30,164
Investing Cash Flow
--
--
--
--
-1,823
Financing Cash Flow
46,781
35,287
41,863
25,345
39,508
End Cash Position
6,966
2,085
6,153
4,139
12,200
Capital Expenditure
--
--
--
--
-1,823
Issuance of Capital Stock
51,602
40,402
43,126
9,000
43,214
Issuance of Debt
--
--
2,200
20,000
8,000
Repayment of Debt
-142
--
-3,463
-2,089
-9,920
Free Cash Flow
-46,556
-35,702
-41,349
-32,958
-31,987
12/31/2021 - 6/10/2016
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade